chr17-82091477-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000306749.4(FASN):c.1237G>A(p.Ala413Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000356 in 1,571,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000306749.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASN | NM_004104.5 | c.1237G>A | p.Ala413Thr | missense_variant | 9/43 | ENST00000306749.4 | NP_004095.4 | |
FASN | XM_011523538.3 | c.1237G>A | p.Ala413Thr | missense_variant | 9/43 | XP_011521840.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.1237G>A | p.Ala413Thr | missense_variant | 9/43 | 1 | NM_004104.5 | ENSP00000304592 | P1 | |
FASN | ENST00000634990.1 | c.1237G>A | p.Ala413Thr | missense_variant | 9/43 | 5 | ENSP00000488964 |
Frequencies
GnomAD3 genomes AF: 0.0000464 AC: 7AN: 150786Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000540 AC: 12AN: 222252Hom.: 0 AF XY: 0.0000740 AC XY: 9AN XY: 121634
GnomAD4 exome AF: 0.0000338 AC: 48AN: 1420870Hom.: 0 Cov.: 35 AF XY: 0.0000424 AC XY: 30AN XY: 707552
GnomAD4 genome AF: 0.0000530 AC: 8AN: 150918Hom.: 0 Cov.: 33 AF XY: 0.0000543 AC XY: 4AN XY: 73730
ClinVar
Submissions by phenotype
Epileptic encephalopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 462001). This variant is present in population databases (rs373548684, ExAC 0.008%). This sequence change replaces alanine with threonine at codon 413 of the FASN protein (p.Ala413Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at